Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000086047 | SCV001205164 | uncertain significance | not provided | 2023-08-24 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects GRM6 function (PMID: 17405131, 19666700). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GRM6 protein function. ClinVar contains an entry for this variant (Variation ID: 5841). This missense change has been observed in individual(s) with congenital night blindness (PMID: 15781871). This variant is present in population databases (rs62638625, gnomAD 0.04%). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 781 of the GRM6 protein (p.Glu781Lys). |
OMIM | RCV000006198 | SCV000026380 | pathogenic | Congenital stationary night blindness 1B | 2005-03-29 | no assertion criteria provided | literature only | |
Retina International | RCV000086047 | SCV000118191 | not provided | not provided | no assertion provided | not provided |